This content is in French.
An innovative platform for pulmonary fibrosis
12 mars 2024
Fibrosing interstitial lung disease is a heterogeneous group of lung diseases associated with significant morbidity and mortality. Despite the number of clinical trials conducted over the past decade, only two…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Leticia Kawano-Dourado et al. Adaptive multi-interventional trial platform to improve patient care for fibrotic interstitial lung diseases. Thorax. 2024 Mar 6:thorax-2023-221148.
View the source
